Detection of Plaque Inflammation and Visualization of Anti-Inflammatory Effects of Pioglitazone on Plaque Inflammation in Subjects With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus by FDG-PET/CT
Phase of Trial: Phase IV
Latest Information Update: 26 Sep 2012
At a glance
- Drugs Pioglitazone (Primary) ; Glimepiride
- Indications Atherosclerosis; Glucose intolerance; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Aug 2008 New trial record.